These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8230132)

  • 1. New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation.
    Cottam HB; Wasson DB; Shih HC; Raychaudhuri A; Di Pasquale G; Carson DA
    J Med Chem; 1993 Oct; 36(22):3424-30. PubMed ID: 8230132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of adenosine kinase and adenosine uptake in guinea-pig CNS tissue by halogenated tubercidin analogues.
    Davies LP; Cook AF
    Life Sci; 1995 Mar; 56(17):PL345-9. PubMed ID: 8847946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues.
    Ugarkar BG; DaRe JM; Kopcho JJ; Browne CE; Schanzer JM; Wiesner JB; Erion MD
    J Med Chem; 2000 Jul; 43(15):2883-93. PubMed ID: 10956196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues.
    Ugarkar BG; Castellino AJ; DaRe JM; Kopcho JJ; Wiesner JB; Schanzer JM; Erion MD
    J Med Chem; 2000 Jul; 43(15):2894-905. PubMed ID: 10956197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo.
    Davies LP; Baird-Lambert J; Marwood JF
    Biochem Pharmacol; 1986 Sep; 35(18):3021-9. PubMed ID: 3019353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms: pharmacological activities and potent inhibition of adenosine kinase.
    Davies LP; Jamieson DD; Baird-Lambert JA; Kazlauskas R
    Biochem Pharmacol; 1984 Feb; 33(3):347-55. PubMed ID: 6322800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices.
    Golembiowska K; White TD; Sawynok J
    Eur J Pharmacol; 1996 Jun; 307(2):157-62. PubMed ID: 8832217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides.
    Ugarkar BG; Castellino AJ; DaRe JS; Ramirez-Weinhouse M; Kopcho JJ; Rosengren S; Erion MD
    J Med Chem; 2003 Oct; 46(22):4750-60. PubMed ID: 14561094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the cytotoxicity and metabolism of 4-amino-3-carboxamido-1-(beta-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine using inhibitors of adenosine kinase and adenosine deaminase.
    Wotring LL; Townsend LB
    Cancer Res; 1979 Aug; 39(8):3018-23. PubMed ID: 222442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy.
    Wiesner JB; Ugarkar BG; Castellino AJ; Barankiewicz J; Dumas DP; Gruber HE; Foster AC; Erion MD
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1669-77. PubMed ID: 10336567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues.
    Boyer SH; Ugarkar BG; Solbach J; Kopcho J; Matelich MC; Ollis K; Gomez-Galeno JE; Mendonca R; Tsuchiya M; Nagahisa A; Nakane M; Wiesner JB; Erion MD
    J Med Chem; 2005 Oct; 48(20):6430-41. PubMed ID: 16190769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells.
    Parkinson FE; Geiger JD
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1397-401. PubMed ID: 8667202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex.
    Hebb MO; White TD
    Eur J Pharmacol; 1998 Mar; 344(2-3):121-5. PubMed ID: 9600645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
    Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor.
    Lee CH; Jiang M; Cowart M; Gfesser G; Perner R; Kim KH; Gu YG; Williams M; Jarvis MF; Kowaluk EA; Stewart AO; Bhagwat SS
    J Med Chem; 2001 Jun; 44(13):2133-8. PubMed ID: 11405650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and study of the anti-inflammatory properties of some pyrazolo[1,5-a]pyrimidine derivatives.
    Bruni F; Costanzo A; Selleri S; Guerrini G; Fantozzi R; Pirisino R; Brunelleschi S
    J Pharm Sci; 1993 May; 82(5):480-6. PubMed ID: 8395598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of rat liver glycogen synthesis by the adenosine kinase inhibitor 5-iodotubercidin.
    Flückiger-Isler RE; Walter P
    Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):85-91. PubMed ID: 8503865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain.
    Lynch JJ; Jarvis MF; Kowaluk EA
    Eur J Pharmacol; 1999 Jan; 364(2-3):141-6. PubMed ID: 9932716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor.
    Massillon D; Stalmans W; van de Werve G; Bollen M
    Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):123-8. PubMed ID: 8166629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.